Nuedexta

Nuedexta Warnings and Precautions

• Thrombocytopenia: Quinidine can cause immune-mediated thrombocytopenia that can be severe or fatal; symptoms such as lightheadedness, chills, fever, nausea, and vomiting may precede or accompany it.
• Hepatotoxicity: Hepatitis has been reported, generally during the first few weeks of treatment; liver function should be monitored.
• QTc prolongation: Nuedexta causes dose-dependent QTc prolongation; it should be used with caution in patients at risk of cardiac arrhythmia, and is contraindicated with certain other QT-prolonging medicines.
• Drug interactions: As a CYP2D6 inhibitor, quinidine can significantly raise levels of other drugs metabolized by this enzyme; patients should review their full medication list with their doctor.

How to Access Nuedexta in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation & Availability

What documents are required to import Nuedexta to India?

Nuedexta (dextromethorphan hydrobromide and quinidine sulfate) capsules may be imported in the patient's name only, by patients or government hospitals, in line with India's import regulations for unapproved medicines. The following documentation is required:

• A valid prescription from a qualified neurologist
• The patient's diagnostic reports confirming pseudobulbar affect associated with a neurologic condition or brain injury
• Patient ID proof (issued by the Government of India)

How is the order confirmed?

The order is confirmed only after receipt and verification of a valid prescription from the doctor and, if applicable, an import permit.

Is Nuedexta available in India?

Nuedexta (dextromethorphan/quinidine capsules) is a prescription medicine that legally requires a doctor's prescription to be dispensed. As of current publicly available information, Nuedexta is not commercially marketed in India.

However, patients in India can legally access Nuedexta through the Named Patient Program (NPP) — an import provision that allows patients to receive medicines approved in other countries but not yet marketed in India, under a doctor's prescription and proper regulatory documentation.

Nuedexta received US FDA approval in 2010 for the treatment of pseudobulbar affect, ensuring full transparency throughout the process.

Nuedexta can be made available to patients, doctors, and hospitals across major cities in India, including Gurgaon, Delhi, Bangalore, Mumbai, Navi Mumbai, Thane, Hyderabad, Mysore, Kerala, Chennai, Coimbatore, Madurai, Kolkata, Ahmedabad, Surat, Vadodara, Pune, Nagpur, Nashik, Jaipur, Udaipur, Lucknow, Kanpur, Gorakhpur, Chandigarh, Mohali, Faridabad, Noida, Ghaziabad, Kochi, Trivandrum, Kozhikode, Thrissur, Kannur, Mangalore, Bhubaneswar, Patna, Ranchi, Raipur, Guwahati, Visakhapatnam, Vijayawada, Goa, Jammu, Srinagar, Dehradun, Bhopal, Indore, Ludhiana, Amritsar, and others.

Sourcing & Delivery of Nuedexta

Nuedexta is sourced directly from authorized channels in the country of origin and shipped to India under GDP-compliant logistics to preserve product integrity from dispatch to delivery.

• Storage maintained at 15°C to 30°C throughout transit
• Real-time shipment tracking and delivery updates
• Delivery coordinated directly with the patient, family, or treating hospital

Availability of Nuedexta Across Major Cities in India

Named Patient Program supports access to Nuedexta for patients with pseudobulbar affect across major cities in India, coordinating documentation, sourcing, and delivery with treating neurologists.

Mumbai

Patients in Mumbai can access Nuedexta through NPP with support from treating neurologists at the city's leading centers.

Delhi

In Delhi, NPP coordinates with hospitals and specialty neurology clinics to facilitate timely access to Nuedexta.

Bangalore

Bangalore's neurology centers work with NPP to support patients requiring Nuedexta.

Chennai

Patients in Chennai can access Nuedexta through NPP, with coordination between treating doctors and the program's regulatory and logistics team.

Hyderabad

Hyderabad's neurology centers support diagnosis and access coordination for Nuedexta through NPP.

Kolkata

NPP facilitates access to Nuedexta for patients in Kolkata under the guidance of treating neurologists.

Pune

Patients in Pune can access Nuedexta through NPP with prescription-based coordination and delivery support.

Ahmedabad

NPP supports access to Nuedexta for patients in Ahmedabad, working directly with treating specialists.

Kochi

Patients in Kochi and across Kerala can access Nuedexta through NPP's regulated import pathway.

Chandigarh

NPP coordinates access to Nuedexta for patients in Chandigarh and the surrounding region.

Jaipur

Patients in Jaipur can access Nuedexta through NPP with support from treating neurologists.

Lucknow

NPP facilitates access to Nuedexta for patients in Lucknow and across Uttar Pradesh.

Bhubaneswar

Patients in Bhubaneswar can access Nuedexta through NPP's coordinated import and delivery process.

Guwahati

NPP supports access to Nuedexta for patients in Guwahati and across the Northeast region.

NPP also supports access for patients in other Indian cities not listed above — contact the team to check availability and timelines for your location.